GLYZIAMET XR TABLET 50:500 Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of GLYZIAMET XR TABLET 50:500.

Available Products of GLYZIAMET XR TABLET 50:500

GLYZIAMET XR TABLET 50:500 14's

Reg#: 092858

Description of GLYZIAMET XR TABLET 50:500

Each modified release film coated tablet contains Sitagliptin 50 mgMetformin HCl 500mg

Medicine Info

Pack Size: 14's

Company: AGP LIMITED

Price of GLYZIAMET XR TABLET 50:500

Price: Rs. 1135.99

Related Keywords

  • GLYZIAMET XR TABLET 50:500 price in Pakistan
  • GLYZIAMET XR TABLET 50:500 tablet price
  • GLYZIAMET XR TABLET 50:500 Capsule price
  • AGP LIMITED GLYZIAMET XR TABLET 50:500 price
  • Buy GLYZIAMET XR TABLET 50:500 online
  • GLYZIAMET XR TABLET 50:500 500mg uses
  • GLYZIAMET XR TABLET 50:500 syrup price
  • GLYZIAMET XR TABLET 50:500 pack 14's cost

GLYZIAMET XR TABLET 50:500 10's

Reg#: 092858

Description of GLYZIAMET XR TABLET 50:500

Each modified release film coated tablet contains Sitagliptin 50 mgMetformin HCl 500mg

Medicine Info

Pack Size: 10's

Company: AGP LIMITED

Price of GLYZIAMET XR TABLET 50:500

Price: Rs. 811.99

Related Keywords

  • GLYZIAMET XR TABLET 50:500 price in Pakistan
  • GLYZIAMET XR TABLET 50:500 tablet price
  • GLYZIAMET XR TABLET 50:500 Capsule price
  • AGP LIMITED GLYZIAMET XR TABLET 50:500 price
  • Buy GLYZIAMET XR TABLET 50:500 online
  • GLYZIAMET XR TABLET 50:500 500mg uses
  • GLYZIAMET XR TABLET 50:500 syrup price
  • GLYZIAMET XR TABLET 50:500 pack 10's cost

Alternatives brands of GLYZIAMET XR TABLET 50:500

Explore alternative brands for GLYZIAMET XR TABLET 50:500 below.

View Alternatives

Explore More Medicines

GLYZIAMET XR 50:1000MG TABLET

AGP LIMITED

MRP: Rs. 1081.9680

GLYZIAMET XR TABLET 100:1000

AGP LIMITED

MRP: Rs. 1354.6080

GLYZIAMET XR TABLET 100:1000

AGP LIMITED

MRP: Rs. 1897.2240

ITOPHIN 50MG TABLET

AGP LIMITED

MRP: Rs. 334.6920

INAPEL 0.1% CREAM

AGP LIMITED

MRP: Rs. 283.9800

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!